Grover Miller
Concepts (235)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Microsomes, Liver | 26 | 2022 | 186 | 6.400 |
Why?
| Cytochrome P-450 CYP2E1 | 14 | 2017 | 113 | 4.970 |
Why?
| Warfarin | 13 | 2018 | 86 | 4.950 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2021 | 121 | 2.970 |
Why?
| Anticoagulants | 10 | 2018 | 250 | 2.920 |
Why?
| Cytochrome P-450 CYP3A | 4 | 2021 | 78 | 2.440 |
Why?
| Kinetics | 19 | 2021 | 623 | 2.000 |
Why?
| Aryl Hydrocarbon Hydroxylases | 6 | 2013 | 74 | 1.690 |
Why?
| Glucuronosyltransferase | 10 | 2019 | 126 | 1.640 |
Why?
| Diphenylamine | 2 | 2021 | 5 | 1.580 |
Why?
| Styrene | 4 | 2015 | 9 | 1.510 |
Why?
| Thiazines | 2 | 2020 | 3 | 1.480 |
Why?
| Models, Biological | 7 | 2018 | 727 | 1.430 |
Why?
| Biotransformation | 10 | 2023 | 86 | 1.400 |
Why?
| Glucuronides | 5 | 2018 | 45 | 1.370 |
Why?
| Metabolic Networks and Pathways | 3 | 2020 | 89 | 1.260 |
Why?
| Substrate Specificity | 10 | 2021 | 194 | 1.110 |
Why?
| Models, Chemical | 7 | 2020 | 66 | 1.000 |
Why?
| Liver | 7 | 2021 | 1115 | 0.980 |
Why?
| Models, Molecular | 6 | 2019 | 338 | 0.850 |
Why?
| Enzyme Inhibitors | 5 | 2019 | 391 | 0.840 |
Why?
| Indazoles | 2 | 2020 | 47 | 0.800 |
Why?
| Stereoisomerism | 7 | 2018 | 104 | 0.780 |
Why?
| Meclofenamic Acid | 1 | 2020 | 2 | 0.760 |
Why?
| Nitrophenols | 4 | 2015 | 16 | 0.760 |
Why?
| Cytochrome P-450 Enzyme System | 6 | 2020 | 195 | 0.750 |
Why?
| Cytochrome P-450 CYP1A2 | 1 | 2020 | 39 | 0.740 |
Why?
| Oxidation-Reduction | 10 | 2017 | 322 | 0.740 |
Why?
| Cannabinoids | 2 | 2020 | 105 | 0.730 |
Why?
| Adamantane | 1 | 2020 | 25 | 0.730 |
Why?
| Humans | 46 | 2023 | 49974 | 0.730 |
Why?
| NADPH-Ferrihemoprotein Reductase | 3 | 2010 | 14 | 0.720 |
Why?
| Computer Simulation | 3 | 2018 | 280 | 0.720 |
Why?
| Binding Sites | 9 | 2015 | 374 | 0.720 |
Why?
| Butadienes | 3 | 2017 | 48 | 0.690 |
Why?
| Protein Binding | 8 | 2015 | 660 | 0.680 |
Why?
| Mitochondria, Liver | 2 | 2017 | 70 | 0.650 |
Why?
| Chromatography, High Pressure Liquid | 4 | 2017 | 349 | 0.630 |
Why?
| Pharmaceutical Preparations | 3 | 2020 | 77 | 0.620 |
Why?
| Pyrazoles | 3 | 2013 | 113 | 0.620 |
Why?
| Oxidoreductases | 2 | 2017 | 60 | 0.610 |
Why?
| Azoles | 2 | 2014 | 28 | 0.600 |
Why?
| Environmental Pollutants | 2 | 2015 | 91 | 0.580 |
Why?
| Aniline Compounds | 2 | 2015 | 43 | 0.580 |
Why?
| Recombinant Proteins | 7 | 2012 | 486 | 0.570 |
Why?
| Carcinogens | 2 | 2017 | 199 | 0.540 |
Why?
| Tandem Mass Spectrometry | 3 | 2011 | 236 | 0.500 |
Why?
| Endoplasmic Reticulum | 1 | 2015 | 108 | 0.490 |
Why?
| Molecular Dynamics Simulation | 1 | 2014 | 33 | 0.490 |
Why?
| Structure-Activity Relationship | 6 | 2021 | 395 | 0.480 |
Why?
| Glutathione | 3 | 2021 | 295 | 0.460 |
Why?
| Thermodynamics | 2 | 2014 | 34 | 0.420 |
Why?
| Molecular Structure | 5 | 2021 | 297 | 0.420 |
Why?
| Acetaminophen | 1 | 2015 | 283 | 0.420 |
Why?
| Hydroxylation | 4 | 2020 | 61 | 0.410 |
Why?
| Catalysis | 7 | 2013 | 88 | 0.380 |
Why?
| Drug Interactions | 2 | 2021 | 206 | 0.370 |
Why?
| Phenotype | 3 | 2018 | 729 | 0.330 |
Why?
| Thiazoles | 2 | 2020 | 52 | 0.330 |
Why?
| Electronic Health Records | 2 | 2021 | 209 | 0.320 |
Why?
| Animals | 11 | 2021 | 13187 | 0.320 |
Why?
| Hydrophobic and Hydrophilic Interactions | 3 | 2014 | 36 | 0.310 |
Why?
| Phenylalanine | 1 | 2008 | 128 | 0.300 |
Why?
| Mass Spectrometry | 3 | 2023 | 306 | 0.300 |
Why?
| Titrimetry | 1 | 2007 | 1 | 0.300 |
Why?
| Multienzyme Complexes | 1 | 2007 | 34 | 0.300 |
Why?
| Inhibitory Concentration 50 | 3 | 2018 | 76 | 0.300 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 19 | 0.280 |
Why?
| Mixed Function Oxygenases | 1 | 2005 | 25 | 0.260 |
Why?
| Chromatography, Liquid | 2 | 2020 | 232 | 0.260 |
Why?
| Lysine | 2 | 2021 | 89 | 0.260 |
Why?
| Catalytic Domain | 2 | 2015 | 57 | 0.250 |
Why?
| Enzyme Activation | 3 | 2013 | 276 | 0.240 |
Why?
| Dose-Response Relationship, Drug | 3 | 2021 | 1376 | 0.230 |
Why?
| Static Electricity | 3 | 2014 | 21 | 0.230 |
Why?
| Benzoquinones | 2 | 2020 | 29 | 0.220 |
Why?
| Binding, Competitive | 2 | 2015 | 94 | 0.210 |
Why?
| Artificial Intelligence | 1 | 2023 | 80 | 0.210 |
Why?
| Epoxy Compounds | 2 | 2020 | 45 | 0.210 |
Why?
| Bacterial Proteins | 1 | 2005 | 376 | 0.200 |
Why?
| Halogenation | 1 | 2021 | 6 | 0.200 |
Why?
| Quinones | 1 | 2021 | 8 | 0.200 |
Why?
| Acetic Acid | 1 | 2021 | 12 | 0.200 |
Why?
| Amino Acid Sequence | 3 | 2014 | 585 | 0.190 |
Why?
| Propionates | 1 | 2021 | 24 | 0.190 |
Why?
| Molecular Sequence Data | 3 | 2014 | 792 | 0.190 |
Why?
| Biological Availability | 1 | 2021 | 122 | 0.190 |
Why?
| Spectrometry, Fluorescence | 1 | 2020 | 45 | 0.190 |
Why?
| Rabbits | 2 | 2014 | 370 | 0.190 |
Why?
| Triazoles | 1 | 2021 | 108 | 0.180 |
Why?
| Data Mining | 1 | 2020 | 39 | 0.180 |
Why?
| Electrons | 1 | 2020 | 19 | 0.180 |
Why?
| Cell Cycle Proteins | 1 | 2021 | 166 | 0.180 |
Why?
| Amino Acid Substitution | 3 | 2010 | 82 | 0.170 |
Why?
| Metabolic Clearance Rate | 1 | 2019 | 68 | 0.170 |
Why?
| Biocatalysis | 1 | 2019 | 15 | 0.170 |
Why?
| Cytochrome P-450 CYP2B1 | 2 | 2010 | 6 | 0.170 |
Why?
| Female | 7 | 2021 | 26472 | 0.160 |
Why?
| Mefenamic Acid | 1 | 2018 | 1 | 0.160 |
Why?
| Indinavir | 1 | 2018 | 1 | 0.160 |
Why?
| Piperacillin | 1 | 2018 | 23 | 0.150 |
Why?
| Verapamil | 1 | 2018 | 21 | 0.150 |
Why?
| Bilirubin | 1 | 2018 | 40 | 0.150 |
Why?
| Databases, Factual | 1 | 2021 | 658 | 0.150 |
Why?
| Cytochromes c | 2 | 2010 | 29 | 0.150 |
Why?
| Osmolar Concentration | 2 | 2010 | 62 | 0.150 |
Why?
| Male | 6 | 2021 | 25241 | 0.150 |
Why?
| Protein Structure, Tertiary | 3 | 2012 | 253 | 0.150 |
Why?
| Cell Line | 2 | 2018 | 1000 | 0.150 |
Why?
| Transcription Factors | 1 | 2021 | 561 | 0.150 |
Why?
| Cytosol | 1 | 2017 | 82 | 0.150 |
Why?
| Serotonin | 1 | 2018 | 152 | 0.140 |
Why?
| Piperazines | 1 | 2018 | 117 | 0.140 |
Why?
| Thiophenes | 1 | 2017 | 36 | 0.140 |
Why?
| Furans | 1 | 2017 | 26 | 0.140 |
Why?
| Hydrogen Bonding | 2 | 2014 | 31 | 0.140 |
Why?
| Pilot Projects | 1 | 2018 | 699 | 0.140 |
Why?
| Kynurenine | 1 | 2015 | 16 | 0.130 |
Why?
| Ligands | 2 | 2014 | 204 | 0.130 |
Why?
| Antifungal Agents | 1 | 2018 | 339 | 0.130 |
Why?
| Phenols | 1 | 2017 | 113 | 0.130 |
Why?
| Liver Neoplasms | 1 | 2019 | 326 | 0.130 |
Why?
| Aspartic Acid | 2 | 2007 | 49 | 0.130 |
Why?
| Genomic Instability | 1 | 2015 | 92 | 0.130 |
Why?
| Protein Transport | 1 | 2015 | 180 | 0.120 |
Why?
| DNA-Directed DNA Polymerase | 1 | 2015 | 92 | 0.120 |
Why?
| Algorithms | 2 | 2021 | 615 | 0.120 |
Why?
| Molecular Docking Simulation | 1 | 2014 | 73 | 0.120 |
Why?
| Cohort Studies | 1 | 2018 | 1422 | 0.120 |
Why?
| Glioblastoma | 1 | 2015 | 92 | 0.120 |
Why?
| Alkanes | 1 | 2014 | 9 | 0.120 |
Why?
| Aged | 3 | 2021 | 9310 | 0.120 |
Why?
| Drug Design | 1 | 2014 | 120 | 0.120 |
Why?
| Middle Aged | 3 | 2021 | 12069 | 0.110 |
Why?
| Enzyme Stability | 1 | 2013 | 20 | 0.110 |
Why?
| Promoter Regions, Genetic | 1 | 2015 | 475 | 0.110 |
Why?
| Mice, Inbred Strains | 1 | 2013 | 161 | 0.110 |
Why?
| Quantitative Structure-Activity Relationship | 2 | 2015 | 32 | 0.110 |
Why?
| Rats, Inbred F344 | 1 | 2013 | 196 | 0.110 |
Why?
| Species Specificity | 1 | 2013 | 192 | 0.110 |
Why?
| Propranolol | 1 | 2013 | 78 | 0.110 |
Why?
| Allosteric Regulation | 1 | 2012 | 13 | 0.110 |
Why?
| Cytochrome P-450 CYP2D6 | 2 | 2002 | 22 | 0.110 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 181 | 0.110 |
Why?
| DNA Adducts | 1 | 2013 | 78 | 0.100 |
Why?
| Disulfides | 1 | 2012 | 17 | 0.100 |
Why?
| Pharmacogenetics | 1 | 2012 | 52 | 0.100 |
Why?
| Protein Multimerization | 1 | 2012 | 49 | 0.100 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 47 | 0.100 |
Why?
| Molecular Chaperones | 1 | 2012 | 64 | 0.100 |
Why?
| Rats, Sprague-Dawley | 1 | 2015 | 1597 | 0.100 |
Why?
| Chromatography, Gas | 1 | 2011 | 14 | 0.100 |
Why?
| Chromatography, Thin Layer | 1 | 2011 | 24 | 0.100 |
Why?
| Isomerism | 1 | 2010 | 22 | 0.090 |
Why?
| Cell Membrane | 1 | 2012 | 248 | 0.090 |
Why?
| Drug Monitoring | 1 | 2011 | 77 | 0.090 |
Why?
| Protein Structure, Quaternary | 1 | 2010 | 26 | 0.090 |
Why?
| Horses | 1 | 2010 | 44 | 0.090 |
Why?
| Protein Structure, Secondary | 1 | 2010 | 72 | 0.090 |
Why?
| Sulfotransferases | 1 | 2010 | 40 | 0.090 |
Why?
| Membrane Proteins | 1 | 2012 | 341 | 0.090 |
Why?
| Cattle | 1 | 2010 | 210 | 0.090 |
Why?
| Aged, 80 and over | 2 | 2021 | 3129 | 0.090 |
Why?
| Mutation, Missense | 1 | 2010 | 105 | 0.080 |
Why?
| Signal Transduction | 1 | 2015 | 1618 | 0.080 |
Why?
| Sequence Homology | 1 | 2008 | 20 | 0.080 |
Why?
| Sensitivity and Specificity | 1 | 2011 | 861 | 0.080 |
Why?
| Mutagenesis | 1 | 2008 | 60 | 0.080 |
Why?
| Metabolomics | 1 | 2009 | 126 | 0.080 |
Why?
| Uridine Diphosphate Glucuronic Acid | 1 | 2007 | 9 | 0.080 |
Why?
| Protein Conformation | 1 | 2008 | 166 | 0.080 |
Why?
| Molecular Conformation | 1 | 2007 | 67 | 0.080 |
Why?
| Mathematical Computing | 1 | 2007 | 7 | 0.080 |
Why?
| Reproducibility of Results | 1 | 2011 | 1193 | 0.070 |
Why?
| Photoaffinity Labels | 1 | 2006 | 15 | 0.070 |
Why?
| Rats | 1 | 2013 | 3305 | 0.070 |
Why?
| Mice | 2 | 2017 | 5739 | 0.070 |
Why?
| Sequence Homology, Amino Acid | 1 | 2006 | 144 | 0.070 |
Why?
| Glutamine | 1 | 2007 | 171 | 0.070 |
Why?
| 2,6-Dichloroindophenol | 1 | 2005 | 1 | 0.070 |
Why?
| Mutation | 2 | 2012 | 1294 | 0.070 |
Why?
| Buffers | 1 | 2005 | 9 | 0.070 |
Why?
| Protein Denaturation | 1 | 2005 | 15 | 0.070 |
Why?
| Biochemistry | 1 | 2005 | 5 | 0.070 |
Why?
| Flavin Mononucleotide | 1 | 2005 | 3 | 0.070 |
Why?
| Dimerization | 1 | 2005 | 52 | 0.060 |
Why?
| Cross-Linking Reagents | 1 | 2005 | 44 | 0.060 |
Why?
| Phosphates | 1 | 2005 | 47 | 0.060 |
Why?
| Oxygen | 1 | 2007 | 326 | 0.060 |
Why?
| Temperature | 1 | 2005 | 168 | 0.060 |
Why?
| Amino Acids | 1 | 2006 | 360 | 0.060 |
Why?
| Spiro Compounds | 1 | 2002 | 8 | 0.050 |
Why?
| Tyramine | 1 | 2002 | 6 | 0.050 |
Why?
| Dealkylation | 2 | 2018 | 4 | 0.050 |
Why?
| Amines | 2 | 2018 | 40 | 0.050 |
Why?
| Sulfonamides | 1 | 2002 | 129 | 0.050 |
Why?
| Models, Statistical | 1 | 2021 | 224 | 0.040 |
Why?
| Sulfurtransferases | 1 | 2019 | 3 | 0.040 |
Why?
| Carboxylesterase | 1 | 2019 | 3 | 0.040 |
Why?
| Oxygenases | 1 | 2019 | 14 | 0.040 |
Why?
| Computational Biology | 1 | 2021 | 214 | 0.040 |
Why?
| Principal Component Analysis | 1 | 2019 | 55 | 0.040 |
Why?
| Cell Survival | 1 | 2021 | 600 | 0.040 |
Why?
| Adolescent | 2 | 2021 | 6356 | 0.040 |
Why?
| Glutathione Transferase | 1 | 2019 | 174 | 0.040 |
Why?
| Aldehydes | 1 | 2018 | 83 | 0.040 |
Why?
| Electron Transport Complex III | 1 | 2017 | 7 | 0.040 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 23 | 0.040 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 25 | 0.040 |
Why?
| Electron Transport Complex I | 1 | 2017 | 23 | 0.040 |
Why?
| Area Under Curve | 1 | 2017 | 182 | 0.040 |
Why?
| DNA Copy Number Variations | 1 | 2017 | 110 | 0.030 |
Why?
| ROC Curve | 1 | 2017 | 232 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 112 | 0.030 |
Why?
| Tumor Cells, Cultured | 1 | 2015 | 465 | 0.030 |
Why?
| Complex Mixtures | 1 | 2014 | 7 | 0.030 |
Why?
| Hazardous Substances | 1 | 2014 | 15 | 0.030 |
Why?
| Indoles | 1 | 2015 | 278 | 0.030 |
Why?
| Time Factors | 1 | 2019 | 2903 | 0.030 |
Why?
| Gene Silencing | 1 | 2012 | 119 | 0.020 |
Why?
| Young Adult | 1 | 2021 | 3958 | 0.020 |
Why?
| Infant | 1 | 2019 | 3567 | 0.020 |
Why?
| Child, Preschool | 1 | 2019 | 3871 | 0.020 |
Why?
| Membrane Glycoproteins | 1 | 2012 | 240 | 0.020 |
Why?
| Retrospective Studies | 1 | 2021 | 6108 | 0.020 |
Why?
| Amino Acid Motifs | 1 | 2007 | 56 | 0.020 |
Why?
| Hepatocytes | 1 | 2009 | 182 | 0.020 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 99 | 0.020 |
Why?
| Cloning, Molecular | 1 | 2007 | 185 | 0.020 |
Why?
| Isoenzymes | 1 | 2007 | 168 | 0.020 |
Why?
| Child | 1 | 2019 | 6847 | 0.020 |
Why?
| Adult | 1 | 2021 | 13236 | 0.020 |
Why?
| Baculoviridae | 1 | 2002 | 5 | 0.010 |
Why?
| NADP | 1 | 2002 | 22 | 0.010 |
Why?
| Hydrogen Peroxide | 1 | 2002 | 115 | 0.010 |
Why?
|
|
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|